These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 6584088

  • 1. [A case of refractory acute lymphocytic leukemia who achieved a complete remission by mitoxantrone].
    Yoshikawa H, Sao H, Tahara T, Akao Y, Yoshikawa S.
    Gan To Kagaku Ryoho; 1984 Mar; 11(3):515-20. PubMed ID: 6584088
    [Abstract] [Full Text] [Related]

  • 2. [A randomized controlled study on vindesine and vincristine in combination with prednisolone in the treatment of adult acute lymphocytic leukemia and blastic crisis of chronic myeloid leukemia].
    Gan To Kagaku Ryoho; 1983 Dec; 10(12):2500-8. PubMed ID: 6580840
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Effects of combination chemotherapy M-VEMFH including mitoxantrone in advanced breast cancer].
    Ito Y, Hoshino A, Ohara K, Kamiya O, Nagata K, Kojima T, Kinoshita T, Sugiura I.
    Gan To Kagaku Ryoho; 1985 Oct; 12(10):1999-2003. PubMed ID: 4051516
    [Abstract] [Full Text] [Related]

  • 6. [Clinical management of acute lymphocytic leukemia in adults. 1. Treatment of acute lymphocytic leukemia with VP (vincristine, prednisolone)--DVMP (daunorubicin, vincristine 6-mercaptopurine, prednisolone) regimen].
    Takahashi I, Uchida K, Ohmoto E, Endo H, Oda Y, Fujimoto S, Hara M, Takaoka K, Watanabe S, Lai M, Kohi F, Kitajima K, Kimura I, Sanada H, Tokioka M, Adachi T, Yorimitsu S.
    Gan To Kagaku Ryoho; 1982 Jul; 9(6):1091-6. PubMed ID: 6964045
    [Abstract] [Full Text] [Related]

  • 7. Hybrid chemotherapy consisting of cyclophosphamide, vincristine, procarbazine, prednisone, doxorubicin, bleomycin, and vinblastine (C-MOPP/ABV) as first-line treatment for patients with advanced Hodgkin disease.
    Montoto S, Camós M, López-Guillermo A, Bosch F, Cervantes F, Blandé J, Esteve J, Cobo F, Nomdedeu B, Campo E, Montserrat E.
    Cancer; 2000 May 01; 88(9):2142-8. PubMed ID: 10813727
    [Abstract] [Full Text] [Related]

  • 8. Sequential combination of methotrexate and L-asparaginase in the treatment of refractory acute leukemia.
    Amadori S, Tribalto M, Pacilli L, De Laurentis C, Papa G, Mandelli F.
    Cancer Treat Rep; 1980 May 01; 64(8-9):939-42. PubMed ID: 6934851
    [Abstract] [Full Text] [Related]

  • 9. [Administration of vindesine sulfate for the treatment of malignant hematological tumors].
    Ueda T, Masaoka T, Shibata H, Kubota Y, Saigo K, Kusakabe H, Takubo T, Nakamura H, Yoshitake J, Ishigami S.
    Gan To Kagaku Ryoho; 1982 Feb 01; 9(2):306-15. PubMed ID: 6764103
    [Abstract] [Full Text] [Related]

  • 10. [Treatment of acute leukemia in relapse].
    Masaoka T.
    Gan To Kagaku Ryoho; 1983 Nov 01; 10(11):2275-80. PubMed ID: 6639089
    [Abstract] [Full Text] [Related]

  • 11. [A case report of macroglobulinemia responded to AAAP-therapy].
    Maruo K, Yoshikawa H, Nagata K.
    Gan To Kagaku Ryoho; 1982 Apr 01; 9(4):733-9. PubMed ID: 6820907
    [Abstract] [Full Text] [Related]

  • 12. [Intermittent-dose ara-C/daunomycin therapy combined with cyclosporin-A and G-CSF led to a fourth remission in a patient with acute promyelocytic leukemia].
    Motomura S, Fujisawa S, Anzai S, Fujimaki K, Hattori M, Fukawa H, Okubo T.
    Rinsho Ketsueki; 1995 Aug 01; 36(8):762-7. PubMed ID: 7563610
    [Abstract] [Full Text] [Related]

  • 13. [Clinical efficacy of a quadruple combination chemotherapy with ACNU, adriamycin, methotrexate, and prednisolone for patients with non-Hodgkin's lymphoma, who were refractory to VEPA (P) treatment].
    Niitsu H, Fukuda M, Fukuda S, Takatsu H, Nakayama Y, Hirokawa M, Mamiya S, Miura I, Takahashi F, Yoshida K.
    Gan To Kagaku Ryoho; 1984 Dec 01; 11(12 Pt 1):2585-9. PubMed ID: 6594975
    [Abstract] [Full Text] [Related]

  • 14. [Short-term intensive consolidation chemotherapy in the treatment of acute nonlymphocytic leukemia].
    Nagata K, Abe Y, Hatanaka T, Ito T, Saito M, Ono Y, Kamiya O, Ohara K.
    Gan To Kagaku Ryoho; 1994 Feb 01; 21(2):231-6. PubMed ID: 8311494
    [Abstract] [Full Text] [Related]

  • 15. [Combination chemotherapy for small cell carcinoma of the lung: AVN-DVC therapy].
    Bando H, Yamashita T, Matunaga Y, Kinoshita S, Doi H, Ogushi F, Shimada H, Tsubura E, Morioka S, Ishimi H.
    Gan To Kagaku Ryoho; 1984 Apr 01; 11(4):888-93. PubMed ID: 6326683
    [Abstract] [Full Text] [Related]

  • 16. Relation between the duration of remission and hyperglycemia during induction chemotherapy for acute lymphocytic leukemia with a hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone/methotrexate-cytarabine regimen.
    Weiser MA, Cabanillas ME, Konopleva M, Thomas DA, Pierce SA, Escalante CP, Kantarjian HM, O'Brien SM.
    Cancer; 2004 Mar 15; 100(6):1179-85. PubMed ID: 15022284
    [Abstract] [Full Text] [Related]

  • 17. [Phase II trial of mitoxantrone in patients with relapsed and refractory acute leukemia].
    Sampi K, Kaneko Y, Maseki N, Kumai R, Sakurai M, Hattori M.
    Gan To Kagaku Ryoho; 1985 Jul 15; 12(7):1453-7. PubMed ID: 4015120
    [Abstract] [Full Text] [Related]

  • 18. A randomized, postremission comparison of four courses of standard-dose consolidation therapy without maintenance therapy versus three courses of standard-dose consolidation with maintenance therapy in adults with acute myeloid leukemia: the Japan Adult Leukemia Study Group AML 97 Study.
    Miyawaki S, Sakamaki H, Ohtake S, Emi N, Yagasaki F, Mitani K, Matsuda S, Kishimoto Y, Miyazaki Y, Asou N, Matsushima T, Takahashi M, Ogawa Y, Honda S, Ohno R, Japan Adult Leukemia Study Group AML 97 Study.
    Cancer; 2005 Dec 15; 104(12):2726-34. PubMed ID: 16284985
    [Abstract] [Full Text] [Related]

  • 19. Comparison of two different schedules of granulocyte-colony-stimulating factor during treatment for acute lymphocytic leukemia with a hyper-CVAD (cyclophosphamide, doxorubicin, vincristine, and dexamethasone) regimen.
    Weiser MA, O'Brien S, Thomas DA, Pierce SA, Lam TP, Kantarjian HM.
    Cancer; 2002 Jan 15; 94(2):285-91. PubMed ID: 11900213
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.